| ■ 영문 제목 : Global Nerve Repair and Regeneration Market 2023-2027
|
 | ■ 상품코드 : IRTNTR74728-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2022년 11월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 세계
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,600,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
테크나비오 조사회사는 세계의 신경 복구 및 재생 시장 규모가 2022년부터 2027년까지 연평균 11.23% 성장하여, 4891.9백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 신경 복구 및 재생 시장에 대해 다방면으로 조사 및 분석하여, 개요, 시장 현황, 시장 규모, 과거 시장 규모, 파이브 포스 분석, 제품별 (뉴로 모듈레이션 디바이스, 바이오 재료) 분석, 용도별 (신경 박리술, 신경 이식, 줄기 세포 치료) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아, 미국, 독일, 중국, 캐나다, 일본, 인도, 기타 지역) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 또한 본 조사 보고서는 Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc., Baxter International Inc., BioWaveGO USA, Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifescie Holdings Corp., KeriMedical SA, LivaNova Plc, Medtronic Plc, NEURONETICS Inc., NeuroPace Inc. 등의 기업 정보가 수록되어 있습니다.
・개요
・시장 현황
・시장 규모
・과거 시장 규모
・파이브 포스 분석
・세계의 신경 복구 및 재생 시장 규모 : 제품별
- 뉴로 모듈레이션 디바이스의 시장 규모
- 바이오 재료의 시장 규모
・세계의 신경 복구 및 재생 시장 규모 : 용도별
- 신경 박리술에 사용되는 신경 복구 및 재생의 시장 규모
- 신경 이식에 사용되는 신경 복구 및 재생의 시장 규모
- 줄기 세포 치료에 사용되는 신경 복구 및 재생의 시장 규모
・고객 현황
・지역별 현황
- 북미의 신경 복구 및 재생 시장 규모
- 유럽의 신경 복구 및 재생 시장 규모
- 아시아의 신경 복구 및 재생 시장 규모
- 미국의 신경 복구 및 재생 시장 규모
- 독일의 신경 복구 및 재생 시장 규모
- 중국의 신경 복구 및 재생 시장 규모
- 캐나다의 신경 복구 및 재생 시장 규모
- 일본의 신경 복구 및 재생 시장 규모
- 인도의 신경 복구 및 재생 시장 규모
- 기타 지역의 신경 복구 및 재생 시장 규모
・추진 요인/과제/동향
・기업 현황
・기업 분석
테크나비오사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 테크나비오사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Nerve Repair and Regeneration Market 2023-2027Technavio has been monitoring the nerve repair and regeneration market and it is poised to grow by $4891.9 mn during 2023-2027, accelerating at a CAGR of 11.23% during the forecast period. Our report on the nerve repair and regeneration market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of neurological disorders, increasing government funds for research on neurological diseases, and the expansion of neurology-related research projects.
Technavio’s nerve repair and regeneration market is segmented as below:
By Product
• Neuromodulation devices
• Biomaterials
By Application
• Neurorrhaphy
• Nerve grafting
• Stem cell therapy
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the technological advancements for nerve repair and regeneration as one of the prime reasons driving the nerve repair and regeneration market growth during the next few years. Also, improvements in stem cell treatment for nerve repair and regeneration and the increasing number of clinical trials will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the nerve repair and regeneration market covers the following areas:
• Nerve repair and regeneration market sizing
• Nerve repair and regeneration market forecast
• Nerve repair and regeneration market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nerve repair and regeneration market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc., Baxter International Inc., BioWaveGO USA, Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifesciences Holdings Corp., KeriMedical SA, LivaNova Plc, Medtronic Plc, NEURONETICS Inc., NeuroPace Inc., NeuroSigma Inc., Polyganics BV, Soterix Medical Inc., Stryker Corp., and Synapse Biomedical Inc. Also, the nerve repair and regeneration market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global nerve repair and regeneration market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global nerve repair and regeneration market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Neuromodulation devices – Market size and forecast 2022-2027
o Exhibit 34: Chart on Neuromodulation devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Neuromodulation devices – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Neuromodulation devices – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Neuromodulation devices – Year-over-year growth 2022-2027 (%)
o 6.4 Biomaterials – Market size and forecast 2022-2027
o Exhibit 38: Chart on Biomaterials – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Biomaterials – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Biomaterials – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Biomaterials – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 43: Chart on Application – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 45: Chart on Comparison by Application
o Exhibit 46: Data Table on Comparison by Application
o 7.3 Neurorrhaphy – Market size and forecast 2022-2027
o Exhibit 47: Chart on Neurorrhaphy – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Neurorrhaphy – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Neurorrhaphy – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Neurorrhaphy – Year-over-year growth 2022-2027 (%)
o 7.4 Nerve grafting – Market size and forecast 2022-2027
o Exhibit 51: Chart on Nerve grafting – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Nerve grafting – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Nerve grafting – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Nerve grafting – Year-over-year growth 2022-2027 (%)
o 7.5 Stem cell therapy – Market size and forecast 2022-2027
o Exhibit 55: Chart on Stem cell therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Stem cell therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Stem cell therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Stem cell therapy – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Application
o Exhibit 59: Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 89: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 93: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 India – Market size and forecast 2022-2027
o Exhibit 101: Chart on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on India – Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on India – Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on India – Year-over-year growth 2022-2027 (%)
o 9.13 Market opportunity By Geographical Landscape
o Exhibit 105: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 106: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 108: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 109: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 110: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 111: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 112: Abbott Laboratories – Overview
o Exhibit 113: Abbott Laboratories – Business segments
o Exhibit 114: Abbott Laboratories – Key news
o Exhibit 115: Abbott Laboratories – Key offerings
o Exhibit 116: Abbott Laboratories – Segment focus
o 12.4 ALEVA NEUROTHERAPEUTICS SA
o Exhibit 117: ALEVA NEUROTHERAPEUTICS SA – Overview
o Exhibit 118: ALEVA NEUROTHERAPEUTICS SA – Product / Service
o Exhibit 119: ALEVA NEUROTHERAPEUTICS SA – Key offerings
o 12.5 AxoGen Inc.
o Exhibit 120: AxoGen Inc. – Overview
o Exhibit 121: AxoGen Inc. – Product / Service
o Exhibit 122: AxoGen Inc. – Key offerings
o 12.6 Baxter International Inc.
o Exhibit 123: Baxter International Inc. – Overview
o Exhibit 124: Baxter International Inc. – Business segments
o Exhibit 125: Baxter International Inc. – Key news
o Exhibit 126: Baxter International Inc. – Key offerings
o Exhibit 127: Baxter International Inc. – Segment focus
o 12.7 Boston Scientific Corp.
o Exhibit 128: Boston Scientific Corp. – Overview
o Exhibit 129: Boston Scientific Corp. – Business segments
o Exhibit 130: Boston Scientific Corp. – Key news
o Exhibit 131: Boston Scientific Corp. – Key offerings
o Exhibit 132: Boston Scientific Corp. – Segment focus
o 12.8 Collagen Matrix Inc.
o Exhibit 133: Collagen Matrix Inc. – Overview
o Exhibit 134: Collagen Matrix Inc. – Product / Service
o Exhibit 135: Collagen Matrix Inc. – Key offerings
o 12.9 Integra Lifesciences Holdings Corp.
o Exhibit 136: Integra Lifesciences Holdings Corp. – Overview
o Exhibit 137: Integra Lifesciences Holdings Corp. – Business segments
o Exhibit 138: Integra Lifesciences Holdings Corp. – Key news
o Exhibit 139: Integra Lifesciences Holdings Corp. – Key offerings
o Exhibit 140: Integra Lifesciences Holdings Corp. – Segment focus
o 12.10 LivaNova Plc
o Exhibit 141: LivaNova Plc – Overview
o Exhibit 142: LivaNova Plc – Business segments
o Exhibit 143: LivaNova Plc – Key offerings
o Exhibit 144: LivaNova Plc – Segment focus
o 12.11 Medtronic Plc
o Exhibit 145: Medtronic Plc – Overview
o Exhibit 146: Medtronic Plc – Business segments
o Exhibit 147: Medtronic Plc – Key news
o Exhibit 148: Medtronic Plc – Key offerings
o Exhibit 149: Medtronic Plc – Segment focus
o 12.12 NEURONETICS Inc.
o Exhibit 150: NEURONETICS Inc. – Overview
o Exhibit 151: NEURONETICS Inc. – Product / Service
o Exhibit 152: NEURONETICS Inc. – Key offerings
o 12.13 NeuroPace Inc.
o Exhibit 153: NeuroPace Inc. – Overview
o Exhibit 154: NeuroPace Inc. – Product / Service
o Exhibit 155: NeuroPace Inc. – Key offerings
o 12.14 Polyganics BV
o Exhibit 156: Polyganics BV – Overview
o Exhibit 157: Polyganics BV – Product / Service
o Exhibit 158: Polyganics BV – Key offerings
o 12.15 Soterix Medical Inc.
o Exhibit 159: Soterix Medical Inc. – Overview
o Exhibit 160: Soterix Medical Inc. – Product / Service
o Exhibit 161: Soterix Medical Inc. – Key offerings
o 12.16 Stryker Corp.
o Exhibit 162: Stryker Corp. – Overview
o Exhibit 163: Stryker Corp. – Business segments
o Exhibit 164: Stryker Corp. – Key news
o Exhibit 165: Stryker Corp. – Key offerings
o Exhibit 166: Stryker Corp. – Segment focus
o 12.17 Synapse Biomedical Inc.
o Exhibit 167: Synapse Biomedical Inc. – Overview
o Exhibit 168: Synapse Biomedical Inc. – Product / Service
o Exhibit 169: Synapse Biomedical Inc. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global nerve repair and regeneration market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Neuromodulation devices – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Neuromodulation devices – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Neuromodulation devices – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Neuromodulation devices – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Biomaterials – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Biomaterials – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Biomaterials – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Biomaterials – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on Application – Market share 2022-2027 (%)
Exhibits44: Data Table on Application – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Application
Exhibits46: Data Table on Comparison by Application
Exhibits47: Chart on Neurorrhaphy – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Neurorrhaphy – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Neurorrhaphy – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Neurorrhaphy – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Nerve grafting – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Nerve grafting – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Nerve grafting – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Nerve grafting – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Stem cell therapy – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Stem cell therapy – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Stem cell therapy – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Stem cell therapy – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Application ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on India – Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on India – Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on India – Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on India – Year-over-year growth 2022-2027 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Impact of drivers and challenges in 2022 and 2027
Exhibits107: Overview on Criticality of inputs and Factors of differentiation
Exhibits108: Overview on factors of disruption
Exhibits109: Impact of key risks on business
Exhibits110: Vendors covered
Exhibits111: Matrix on vendor position and classification
Exhibits112: Abbott Laboratories – Overview
Exhibits113: Abbott Laboratories – Business segments
Exhibits114: Abbott Laboratories – Key news
Exhibits115: Abbott Laboratories – Key offerings
Exhibits116: Abbott Laboratories – Segment focus
Exhibits117: ALEVA NEUROTHERAPEUTICS SA – Overview
Exhibits118: ALEVA NEUROTHERAPEUTICS SA – Product / Service
Exhibits119: ALEVA NEUROTHERAPEUTICS SA – Key offerings
Exhibits120: AxoGen Inc. – Overview
Exhibits121: AxoGen Inc. – Product / Service
Exhibits122: AxoGen Inc. – Key offerings
Exhibits123: Baxter International Inc. – Overview
Exhibits124: Baxter International Inc. – Business segments
Exhibits125: Baxter International Inc. – Key news
Exhibits126: Baxter International Inc. – Key offerings
Exhibits127: Baxter International Inc. – Segment focus
Exhibits128: Boston Scientific Corp. – Overview
Exhibits129: Boston Scientific Corp. – Business segments
Exhibits130: Boston Scientific Corp. – Key news
Exhibits131: Boston Scientific Corp. – Key offerings
Exhibits132: Boston Scientific Corp. – Segment focus
Exhibits133: Collagen Matrix Inc. – Overview
Exhibits134: Collagen Matrix Inc. – Product / Service
Exhibits135: Collagen Matrix Inc. – Key offerings
Exhibits136: Integra Lifesciences Holdings Corp. – Overview
Exhibits137: Integra Lifesciences Holdings Corp. – Business segments
Exhibits138: Integra Lifesciences Holdings Corp. – Key news
Exhibits139: Integra Lifesciences Holdings Corp. – Key offerings
Exhibits140: Integra Lifesciences Holdings Corp. – Segment focus
Exhibits141: LivaNova Plc – Overview
Exhibits142: LivaNova Plc – Business segments
Exhibits143: LivaNova Plc – Key offerings
Exhibits144: LivaNova Plc – Segment focus
Exhibits145: Medtronic Plc – Overview
Exhibits146: Medtronic Plc – Business segments
Exhibits147: Medtronic Plc – Key news
Exhibits148: Medtronic Plc – Key offerings
Exhibits149: Medtronic Plc – Segment focus
Exhibits150: NEURONETICS Inc. – Overview
Exhibits151: NEURONETICS Inc. – Product / Service
Exhibits152: NEURONETICS Inc. – Key offerings
Exhibits153: NeuroPace Inc. – Overview
Exhibits154: NeuroPace Inc. – Product / Service
Exhibits155: NeuroPace Inc. – Key offerings
Exhibits156: Polyganics BV – Overview
Exhibits157: Polyganics BV – Product / Service
Exhibits158: Polyganics BV – Key offerings
Exhibits159: Soterix Medical Inc. – Overview
Exhibits160: Soterix Medical Inc. – Product / Service
Exhibits161: Soterix Medical Inc. – Key offerings
Exhibits162: Stryker Corp. – Overview
Exhibits163: Stryker Corp. – Business segments
Exhibits164: Stryker Corp. – Key news
Exhibits165: Stryker Corp. – Key offerings
Exhibits166: Stryker Corp. – Segment focus
Exhibits167: Synapse Biomedical Inc. – Overview
Exhibits168: Synapse Biomedical Inc. – Product / Service
Exhibits169: Synapse Biomedical Inc. – Key offerings
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations
|
| ※본 조사보고서 [세계의 신경 복구 및 재생 시장 (2023년~2027년)] (코드 : IRTNTR74728-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 신경 복구 및 재생 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요! 세계의 신경 복구 및 재생 시장 (2023년~2027년)
